Rosa P, Bono J, Elias A, Errett J, Kupko J, Stevenson B, Taylor G, Tilly K
Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Wien Klin Wochenschr. 1998 Dec 23;110(24):859-62.
Borrelia burgdorferi, the agent of Lyme disease, has recently joined a growing number of micro-organisms for which the entire genomic sequence is known. Despite this wealth of information, little is known about the contribution of specific spirochetal components to the pathogenesis of Lyme disease or their function in the normal life cycle of the organism. This discrepancy is due in part to the lack of a well-developed genetic system in B. burgdorferi, which in turn can be attributed to its relatively recent isolation and the dissimilarity of Borrelia from other genetically tractable bacteria. We are interested in several plasmid-encoded gene products in B. burgdorferi that may play a role in sensing and adaptation to the different environments the spirochete encounters as it completes an infectious cycle between the tick vector and the mammalian host. We are developing genetic tools with which to test the roles of specific B. burgdorferi gene products in the transmission cycle in an animal model of Lyme disease. We have demonstrated targeted gene inactivation by allelic exchange, using the gyrBr gene encoding coumermycin-resistant topoisomerase as a selectable marker. Spirochetes are transformed by electroporation and coumermycin-resistant colonies are screened by PCR for allelic exchange at the targeted locus. We have successfully inactivated several genes of interest in the type strain B31. We are investigating the utility of additional antibiotic resistance genes as selectable markers in B. burgdorferi. Targeted gene inactivation is a powerful tool with which to investigate the role of particular proteins in the basic biology and virulence of a pathogenic microorganism. We have made significant advances in our ability to genetically manipulate B. burgdorferi in order to address these issues. However, the available methods are incomplete and far from routine. We are currently improving existing methods as well as developing additional genetic tools with which to augment genetic studies in B. burgdorferi.
莱姆病的病原体伯氏疏螺旋体,最近加入了越来越多已知全基因组序列的微生物行列。尽管有如此丰富的信息,但对于特定螺旋体成分在莱姆病发病机制中的作用或它们在该生物体正常生命周期中的功能,人们却知之甚少。这种差异部分归因于伯氏疏螺旋体缺乏完善的遗传系统,而这又可归因于其相对较新的分离以及伯氏疏螺旋体与其他易于进行基因操作的细菌的差异。我们对伯氏疏螺旋体中几种质粒编码的基因产物感兴趣,这些产物可能在螺旋体在蜱虫媒介和哺乳动物宿主之间完成感染周期时,感知并适应其所遇到的不同环境中发挥作用。我们正在开发遗传工具,以在莱姆病动物模型中测试特定伯氏疏螺旋体基因产物在传播周期中的作用。我们已经证明了通过等位基因交换进行靶向基因失活,使用编码抗香豆霉素拓扑异构酶的gyrBr基因作为选择标记。通过电穿孔转化螺旋体,并通过PCR筛选抗香豆霉素菌落,以检测在靶向位点的等位基因交换。我们已经成功地使模式菌株B31中的几个感兴趣的基因失活。我们正在研究其他抗生素抗性基因作为伯氏疏螺旋体选择标记的效用。靶向基因失活是一种强大的工具,可用于研究特定蛋白质在致病微生物的基础生物学和毒力中的作用。为了解决这些问题,我们在对伯氏疏螺旋体进行基因操作的能力方面取得了重大进展。然而,现有的方法并不完善,远非常规方法。我们目前正在改进现有方法,并开发额外的遗传工具,以加强对伯氏疏螺旋体的遗传研究。